Webinars

A look at 20 tracked categories, and where the next generation of branded strains can lead.

Beyond Digestion: Where Probiotic Demand Is Outrunning the Shelf explores how the probiotic category is rapidly evolving beyond traditional gut health into a much broader landscape of consumer demand. Drawing from millions of data points across products, ingredients, clinical trials, search behavior, and consumer conversations, Afif Ghannoum, Founder & CEO of CPG Radar, reveals where probiotic innovation is accelerating, where the market is underserved, and why strain-specific science is becoming the new competitive advantage.

Attendees will receive a data-driven deep dive into the emerging probiotic opportunities currently shaping the market. We’ll explore high-growth categories—including women’s wellness, metabolic health, and sports nutrition—to show you exactly where the next generation of product innovation is headed.

The session will unpack why today’s consumers are increasingly demanding named strains, human clinical evidence, and condition-specific solutions, while generic “blend” positioning loses traction. The talk will also explore how brands and ingredient companies can identify the highest-growth whitespace opportunities and position clinically substantiated strains to win in an increasingly sophisticated marketplace.

A look at 20 tracked categories, and where the next generation of branded strains can lead.

Beyond Digestion: Where Probiotic Demand Is Outrunning the Shelf explores how the probiotic category is rapidly evolving beyond traditional gut health into a much broader landscape of consumer demand. Drawing from millions of data points across products, ingredients, clinical trials, search behavior, and consumer conversations, Afif Ghannoum, Founder & CEO of CPG Radar, reveals where probiotic innovation is accelerating, where the market is underserved, and why strain-specific science is becoming the new competitive advantage.

As a benefit of our partnership, CPG Radar customers will receive an exclusive, data-driven deep dive into the emerging probiotic opportunities currently shaping the market. We’ll explore high-growth categories—including women’s wellness, metabolic health, and sports nutrition—to show you exactly where the next generation of product innovation is headed.

The session will unpack why today’s consumers are increasingly demanding named strains, human clinical evidence, and condition-specific solutions, while generic “blend” positioning loses traction. The talk will also explore how brands and ingredient companies can identify the highest-growth whitespace opportunities and position clinically substantiated strains to win in an increasingly sophisticated marketplace.

Creatine is one of the most studied and widely used ingredients in supplements, but nearly all of its innovation and positioning remains anchored in sports nutrition. At the same time, consumer behavior is shifting in a way the market has not caught up to, with women now driving the majority of search interest around creatine, while almost no products are designed specifically for them.

In this session, we’ll break down how this gap exists, and why it’s invisible to most brands. We’ll show how one of the most established ingredients in the industry is quietly becoming one of the largest untapped opportunities in women’s wellness.

We’ll then translate these insights into concrete product concepts, formulation strategies, and positioning angles that brands can act on immediately.

What You’ll Learn

• The Hidden Demand Shift in Creatine: Why women now represent the majority of creatine-related search interest, and what that signals about where the category is moving.
• Why Brands Haven’t Moved (Yet): The structural reasons incumbents remain anchored in sports nutrition, and why that creates a window for new entrants.
• The Barrier No One Is Addressing: How concerns like bloating and water retention are shaping adoption.
• Winning Product & Formulation Strategies: What the data suggests around…
• Format (capsules vs. powders)
• Dose strategy
• Claim construction grounded in clinical evidence
• How to Enter Before Incumbents Do: A practical approach to building a defensible position before large brands reposition and close the gap.

Who Should Attend?

• Product Development Leaders: Looking to unlock new growth platforms using proven ingredients in underdeveloped categories.
• Brand Leaders & Innovation Teams: Seeking differentiated positioning in crowded markets like sports nutrition and longevity.
• Ingredient Suppliers & Commercial Teams: Wanting to reframe how creatine (and similar ingredients) can be positioned to new audiences.
• Marketing & Strategy Teams: Responsible for translating clinical evidence into messaging that resonates with specific consumer segments.

GLP-1 medications have reshaped weight management, but they’ve also created a set of predictable, under-addressed consumer challenges. GLP-1 users follow a predictable, multi-phase journey, creating distinct product needs at each stage of treatment.

In this webinar, we’ll show how search behavior, real consumer experience, and clinical research align to reveal where supplement products can play a credible, defensible role as GLP-1 companion products. This session is not about chasing trends. It’s about designing products and portfolios that match how GLP-1 users actually experience the journey.

What You’ll Learn

In this session, you’ll learn:

• Why GLP-1 is not a single product opportunity, but a multi-phase consumer journey spanning initiation, titration, transformation, maintenance, and discontinuation
• Which GLP-1 side effects and concerns are both highly searched and clinically substantiated, and where brands should be cautious
• How current GLP-1 companion products are being positioned, and where true white space still exists
• What a multi-phase product strategy looks like in practice, including implications for formats, claims, and portfolio design
• How to think about GLP-1 companions as a long-term growth platform, not a short-term trend tied only to active medication use

Who This Webinar Is For

This webinar is designed for:

• Product development, innovation, and R&D leaders at supplement brands
• Marketing and brand teams evaluating GLP-1 companion positioning
• Commercial and strategy leaders assessing GLP-1 as a portfolio-level opportunity
• Ingredient suppliers supporting customers in GLP-1–adjacent innovation

About the Host

Afif Ghannoum is the Founder and CEO of CPG Radar, a market intelligence platform used by leading supplement brands and ingredient suppliers to guide product innovation and go-to-market strategy.

Afif works at the intersection of consumer search behavior, clinical research, and competitive market dynamics. He has led GLP-1 landscape analyses for multiple partners, helping teams understand where demand, science, and defensible product opportunities truly align.